Variables | Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|---|
OR (95%CI) | P | OR (95%CI) | P | ||
Age, y | 1.030 (0.971–1.093) | 0.330 | |||
Male, n (%) | 1.913 (1.084–3.375) | 0.025 | 1.925 (0.818–4.531) | 0.134 | |
BMI (kg/m 2) | 0.962 (0.891–1.038) | 0.321 | |||
Concomitant diseases, n (%) | |||||
 Diabetes | 1.704 (0.752–3.858) | 0.201 | |||
 Hypertension | 0.620 (0.351–1.096) | 0.100 | |||
 COPD | 1.603(0.143–17.976) | 0.702 | |||
 Cerebrovascular disease | 2.221 (0.912–5.405) | 0.079 | |||
NYHA ≧ 3, n (%) | 1.318 (0.751–2.314) | 0.336 | |||
CONUT ≧ 2, n (%) | 2.450 (1.272–4.717) | 0.007 | 0.908 (0.799–1.031) | 0.137 | |
Preoperative laboratory tests | |||||
 Serum albumin, g/dL | 0.824 (0.744–0.913) | < 0.001 | 0.896 (0.790–1.017) | 0.090 | |
 Triglyceride, mmol/L | 0.864 (0.589–1.268) | 0.456 | |||
 LDL-C, mmol/L | 0.934 (0.654–1.333) | 0.705 | |||
 HDL-C, mmol/L | 0.613 (0.275–1.369) | 0.233 | |||
 Creatinine, mg/dL | 1.021 (1.008–1.034) | 0.002 | 1.005 (0.983–1.027) | 0.677 | |
 eGFR, mL/min/1.73 m2 | 0.983 (0.972–0.995) | 0.005 | 0.990 (0.969–1.011) | 0.346 | |
 Hemoglobin, g/L | 0.988 (0.972–1.004) | 0.142 | |||
 WBC, ×10 9/L | 1.100 (1.010–1.198) | 0.028 | 1.098(0.991–1.217) | 0.074 | |
 Lymphocytes, ×109/L | 0.523 (0.310–0.883) | 0.015 | 0.738(0.375–1.454) | 0.380 | |
Type of surgery, n (%) | |||||
 Valve | Reference | ||||
 Valve + aorta | 2.689 (1.297–5.573) | 0.008 | 1.273 (0.491-3.300) | 0.620 | |
 Valve + Other | 1.618 (0.831–3.151) | 0.157 | 0.940 (0.396–2.231) | 0.889 | |
Intraoperative time, min | |||||
 Surgical time | 1.011 (1.007–1.015) | < 0.001 | 1.008 (1.001–1.015) | 0.023 | |
 CPB time | 1.018 (1.012–1.025) | < 0.001 | |||
 Aortic cross-clamp time | 1.019 (1.011–1.026) | < 0.001 | 1.009 (0.998–1.020) | 0.112 | |
Sarcopenia | |||||
 No | Reference | ||||
 Yes | 2.626 (1.447–4.766) | 0.002 | 2.457 (1.178–5.126) | 0.017 |